XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive (loss) income
Total
Beginning balance at Dec. 31, 2023 $ 17 $ 1,958,909 $ (1,519,950) $ 13,787 $ 452,763
Beginning balance (in shares) at Dec. 31, 2023 172,083,667        
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options   17     17
Exercise of stock options (in shares) 8,677        
Vesting of restricted stock awards and units (in shares) 3,444,670        
Vesting of performance-based stock units (in shares) 288,672        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (3,035)     (3,035)
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (1,089,888)        
Stock-based compensation expense   12,061     12,061
Other comprehensive loss       (5,673) (5,673)
Net loss     (60,599)   (60,599)
Ending balance at Sep. 30, 2024 $ 17 1,967,952 (1,580,549) 8,114 395,534
Ending balance (in shares) at Sep. 30, 2024 174,735,798        
Beginning balance at Jun. 30, 2024 $ 17 1,964,304 (1,567,127) 7,828 405,022
Beginning balance (in shares) at Jun. 30, 2024 174,437,242        
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options (in shares) 53        
Vesting of restricted stock awards and units (in shares) 417,633        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (397)     (397)
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (119,130)        
Stock-based compensation expense   4,045     4,045
Other comprehensive loss       286 286
Net loss     (13,422)   (13,422)
Ending balance at Sep. 30, 2024 $ 17 1,967,952 (1,580,549) 8,114 395,534
Ending balance (in shares) at Sep. 30, 2024 174,735,798        
Beginning balance at Dec. 31, 2024 $ 18 1,970,708 (1,574,185) 8,080 $ 404,621
Beginning balance (in shares) at Dec. 31, 2024 175,599,250       175,599,250
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options   6     $ 6
Exercise of stock options (in shares) 3,997        
Exercise of warrants   150     150
Exercise of warrants (in shares) 32,573        
Repurchase of common stock   (5,731)     $ (5,731)
Repurchase of common stock (in shares) (1,483,902)       (1,500,000)
Vesting of restricted stock awards and units (in shares) 2,922,214        
Vesting of performance-based stock units (in shares) 423,677        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (3,827)     $ (3,827)
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (1,021,317)        
Stock-based compensation expense   14,619     14,619
Other comprehensive loss       (357) (357)
Net loss     (49,429)   (49,429)
Ending balance at Sep. 30, 2025 $ 18 1,975,925 (1,623,614) 7,723 $ 360,052
Ending balance (in shares) at Sep. 30, 2025 176,476,492       176,476,492
Beginning balance at Jun. 30, 2025 $ 18 1,973,990 (1,611,505) 7,932 $ 370,435
Beginning balance (in shares) at Jun. 30, 2025 177,156,341        
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options (in shares) 300        
Repurchase of common stock   (3,478)     $ (3,478)
Repurchase of common stock (in shares) (911,092)       (900,000)
Vesting of restricted stock awards and units (in shares) 297,586        
Vesting of performance-based stock units (in shares) 45,926        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (431)     $ (431)
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (112,569)        
Stock-based compensation expense   5,844     5,844
Other comprehensive loss       (209) (209)
Net loss     (12,109)   (12,109)
Ending balance at Sep. 30, 2025 $ 18 $ 1,975,925 $ (1,623,614) $ 7,723 $ 360,052
Ending balance (in shares) at Sep. 30, 2025 176,476,492       176,476,492